Manufacturer record
Ipca Laboratories Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Ipca Laboratories Ltd (Uttarakhand) were declared Not of Standard Quality between March 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
9 records linked to Ipca Laboratories Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets | FND0825055AKMfg 2025-12 · Exp 2028-05 | Identity test negative for Aceclofenac and ParacetamolOther | Lucknow LabState lab | Jul 2026 |
| Aceclofenac, Paracetamol & Serratiopeptidase Tablets | FND0826009AKMfg 2026-02 · Exp 2028-07 | Description Rough surface on each Tablets.Description | SDFTL US Nagar,UKState lab | Jun 2026 |
| Paracetamol Tablets IP 650mg | GMW0825055AKMfg 2025-10 · Exp 2028-09 | The sample received does not conform to I.P. 2022 with respect to the test for DissolutionDissolution | CDTL, MumbaiCDSCO lab | Mar 2026 |
| Ceftriaxone & Sulbactam for Injection IP (Keftragard-1500) | KPD034021AQMfg 2024-07 · Exp 2026-06 | MisbrandedMisbranded | SDTL Raipur ChhattisgarhState lab | Dec 2025 |
| Paracetamol 250 mg & Mefenamic Acid 100 mg Suspension, 60 ml (Pacimol MF 250 Suspension) | INC014022RMfg 2024-04 · Exp 2026-03 | Assay of Paracetamol and Mefenamic AcidAssay | CDTL-MumbaiCDSCO lab | May 2025 |
| Aceclofenac 100 mg, Serratiopeptidas e 15 mg & Paracetamol 325 mg Tablets(ZEROD OL-SP TABLETS) | FND033076 ASMfg 2023-08 · Exp 2026-01 | Identification and Assay of Aceclofenac Serratiopeptidas e and ParacetamolAssay | RDTL ChandigarhCDSCO lab | Sep 2024 |
| Prednisolone Tablets IP 5 mg | DTB-130Mfg 2022-01 · Exp 2023-12 | Related SubstancesRelated substances | RDTL ChandigarhCDSCO lab | Jan 2023 |
| Aceclofenac 100 mg & Thiocolchicoside 4 mg Tablets (Zerodol TH 4 Tablets) | FXT012008ASMfg 2022-03 · Exp 2025-02 | Identification and Assay of ThiocolchicosideAssay | RDTL ChandigarhState lab | Jan 2023 |
| Atormax-20 (Atorvastatin Tablets 20 mg) | FVQ028029Mfg 2018-08 · Exp 2020-07 | DissolutionDissolution | CDTL MumbaiCDSCO lab | Mar 2019 |
Batches reported as suspected spurious under this label
CDSCO's spurious-drug alerts list batches that purport to be made by a company but are suspected counterfeits. The labelled manufacturer's reply is shown where CDSCO published it.
| Product | Batch | Reported by | Firm's reply | Alert |
|---|---|---|---|---|
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets Zerodol-SP | FND072001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
| Aceclofenac 100 mg, Serratiopeptidase 15 mg & Paracetamol 325 mg Tablets ZERODOL-SP TABLETS | FND0725001BH | RDTL, Chandigarh | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. | Dec 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.